Back to Search
Start Over
Additional file 1 of Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial
Additional file 1 of Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial
- Publication Year :
- 2022
- Publisher :
- figshare, 2022.
-
Abstract
- Additional file 1: Supplementary Methods, Results, Tables and Figures.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....54b557f152d8e93631c06c6226d05355
- Full Text :
- https://doi.org/10.6084/m9.figshare.21564179